BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 26510091)

  • 1. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum.
    Murakami T; Mitomi H; Saito T; Takahashi M; Sakamoto N; Fukui N; Yao T; Watanabe S
    Mod Pathol; 2015 Jan; 28(1):146-58. PubMed ID: 24925057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions.
    Naito T; Nosho K; Ito M; Igarashi H; Mitsuhashi K; Yoshii S; Aoki H; Nomura M; Sukawa Y; Yamamoto E; Adachi Y; Takahashi H; Hosokawa M; Fujita M; Takenouchi T; Maruyama R; Suzuki H; Baba Y; Imai K; Yamamoto H; Ogino S; Shinomura Y
    World J Gastroenterol; 2014 Aug; 20(29):10050-61. PubMed ID: 25110432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of "sessile serrated" adenoma to carcinoma transition in six early colorectal cancers.
    Cappellesso R; Lo Mele M; Munari G; Rosa-Rizzotto E; Guido E; De Lazzari F; Pilati P; Tonello M; Farinati F; Realdon S; Fassan M; Rugge M
    Pathol Res Pract; 2019 May; 215(5):957-962. PubMed ID: 30738693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colorectal serrated adenoma: diagnostic criteria and clinical implications].
    Rüschoff J; Aust D; Hartmann A
    Verh Dtsch Ges Pathol; 2007; 91():119-25. PubMed ID: 18314605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
    Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
    Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
    García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
    Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
    Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
    Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.
    Kambara T; Simms LA; Whitehall VL; Spring KJ; Wynter CV; Walsh MD; Barker MA; Arnold S; McGivern A; Matsubara N; Tanaka N; Higuchi T; Young J; Jass JR; Leggett BA
    Gut; 2004 Aug; 53(8):1137-44. PubMed ID: 15247181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article.
    Sambuudash O; Kim HM; Jo H; Kim HS; Lee KJ; Park HJ; Kim JW; Cho MY; Kim HS
    Medicine (Baltimore); 2016 Dec; 95(49):e5592. PubMed ID: 27930579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
    Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
    Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.